Multiple Sclerosis

MS or multiple sclerosis is the most common serious neurological disease in young adults.

Bayer Schering Pharma's MS medication is indicated for the treatment of relapsing-remitting MS. In 2006, the therapeutic indication was extended to cover the treatment of early MS as well. Bayer Schering Pharma also supports individual patient care by providing MS-related materials and services, such as an Internet web site with a chat forum.